Literature DB >> 21250973

Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules.

Thomas Lehrnbecher1, Ralf Schubert, Regina Allwinn, Kader Dogan, Ulrike Koehl, Hans-Peter Grüttner.   

Abstract

Given that a significant proportion of children with acute lymphoblastic leukaemia (ALL) lose immune protection to tetanus, diphtheria, and poliomyelitis, revaccination is indicated after chemotherapy. Our randomized pilot study comparing different revaccination schedules suggests that children with ALL might be revaccinated with non-live vaccines as early as 3 months after chemotherapy.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21250973     DOI： 10.1111/j.1365-2141.2010.08522.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  4 in total

Review 1.  Vaccination against infectious diseases: what is promising?

Authors:  Hans Wilhelm Doerr; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2014-07-27       Impact factor: 3.402

Review 2.  Immune function in childhood cancer survivors: a Children's Oncology Group review.

Authors:  Gregory M T Guilcher; Linda Rivard; Jennifer T Huang; Nicola A M Wright; Lynette Anderson; Hesham Eissa; Wendy Pelletier; Shanti Ramachandran; Tal Schechter; Ami J Shah; Ken Wong; Eric J Chow
Journal:  Lancet Child Adolesc Health       Date:  2021-02-16

3.  Dynamic re-immunization of off-treatment childhood cancer survivors: An implementation feasibility study.

Authors:  Jennifer H Han; Kathryn M Harmoney; Elif Dokmeci; Jacqueline Torrez; Cathy M Chavez; Loretta Cordova de Ortega; John F Kuttesch; Martha Muller; Stuart S Winter
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

4. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.